These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6328330)

  • 21. Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases.
    Griesbacher T; Leighton GE; Hill RG; Hughes J
    Br J Pharmacol; 1989 Jan; 96(1):236-42. PubMed ID: 2647203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apomorphine separates the antinociceptive effects of cholecystokinin octapeptide and ceruletide from those of morphine.
    Zetler G
    Eur J Pharmacol; 1983 Aug; 92(1-2):151-4. PubMed ID: 6313385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic projection to the central amygdala mediates the facilitatory effect of CCK-8US and caerulein on memory in rats.
    Winnicka MM; Wiśniewski K
    Pharmacol Res; 1999 Jun; 39(6):445-50. PubMed ID: 10373247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Naloxone-resistant EEG slowing induced by the synthetic opioid peptide FK 33-824 in the 4th cerebral ventricle of the dog].
    Freye E; Schenk GK; Hartung E
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1982 Sep; 13(3):129-32. PubMed ID: 6293796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caerulein and its analogues: neuropharmacological properties.
    Zetler G
    Peptides; 1985; 6 Suppl 3():33-46. PubMed ID: 3913910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressive effects of cholecystokinin and bombesin on growth hormone and prolactin secretion in urethane-anesthetized rats.
    Karashima T; Okajima T; Kato K; Ibayashi H
    Endocrinol Jpn; 1984 Oct; 31(5):539-47. PubMed ID: 6097442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the mode of action of methionine enkephalin, FK 33-824 and naloxone in regulating the hemolymph glucose level in the fresh water field crab Oziotelphusa senex senex.
    Reddy PS; Basha MR
    Z Naturforsch C J Biosci; 2001; 56(7-8):629-32. PubMed ID: 11531100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceruletide acts in the abdomen, not in the brain, to produce satiety.
    Smith GP; Jerome C; Kulkosky P; Simansky KJ
    Peptides; 1984; 5(6):1149-57. PubMed ID: 6099563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma CCK levels after food intake and infusion of CCK analogues that inhibit feeding in dogs.
    Reidelberger RD; Kalogeris TJ; Solomon TE
    Am J Physiol; 1989 May; 256(5 Pt 2):R1148-54. PubMed ID: 2719157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of cholecystokinin octapeptide in the central control of food intake in the dog.
    Sakatani N; Inui A; Inoue T; Oya M; Morioka H; Baba S
    Peptides; 1987; 8(4):651-6. PubMed ID: 3306623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonidine and yohimbine separate the sedation and the ptosis caused by cholecystokinin octapeptide and ceruletide.
    Zetler G
    Eur J Pharmacol; 1984 Jul; 102(2):333-40. PubMed ID: 6090162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholecystokinin octapeptide activates an opioid mechanism in the guinea-pig ileum: a possible role for substance P.
    Garzón J; Höllt V; Herz A
    Eur J Pharmacol; 1987 Apr; 136(3):361-70. PubMed ID: 2440699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exogenous opioid regulation of the hypothalamic-pituitary-adrenal axis in fetal sheep.
    Brooks AN; Challis JR
    J Endocrinol; 1988 Dec; 119(3):389-95. PubMed ID: 2851636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of deprivation-induced feeding by naloxone and cholecystokinin in rats: effects of central alloxan.
    Arjune D; Bodnar RJ
    Brain Res Bull; 1990 Mar; 24(3):375-9. PubMed ID: 2337818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
    Noble F; Smadja C; Roques BP
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze.
    Kõks S; Soosaar A; Võikar V; Volke V; Ustav M; Männistö PT; Bourin M; Vasar E
    Neuropeptides; 1998 Jun; 32(3):235-40. PubMed ID: 10189057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of enkephalins and the analogue FK-33824 on mean arterial pressure and heart rate in conscious sheep.
    Wang XM; Tresham JJ; Scoggins BA; Coghlan JP
    Clin Exp Hypertens A; 1989; 11(3):427-45. PubMed ID: 2743583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat.
    Itoh S; Takashima A; Igano K; Inouye K
    Peptides; 1989; 10(4):843-8. PubMed ID: 2531375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extreme hyperthermia induced in cats by the enkephalin analog FK 33-824.
    Clark WG; Bernardini GL; Ponder SW
    Pharmacol Biochem Behav; 1982 Jun; 16(6):989-93. PubMed ID: 6287503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid.
    Zetler G
    Neurosci Lett; 1981 Jul; 24(2):175-80. PubMed ID: 6265841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.